A study of ISA101 and cemiplimab (REGN2810) combination treatment in cervical cancer.
Latest Information Update: 22 Dec 2017
At a glance
- Drugs Cemiplimab (Primary) ; ISA 101 (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 22 Dec 2017 New trial record